Showing 281 - 300 results of 922 for search 'Grade 22', query time: 0.08s Refine Results
  1. 281

    Virtual Reality Interventions for Older Adults With Mild Cognitive Impairment: Systematic Review and Meta-Analysis of Randomized Controlled Trials by Qin Yang, Liuxin Zhang, Fangyuan Chang, Hongyi Yang, Bin Chen, Zhao Liu

    Published 2025-01-01
    “…A meta-analysis, risk-of-bias sensitivity analysis, and subgroup analysis were performed where appropriate to explore potential moderators. The Grading of Recommendations, Assessment, Development, and Evaluations (GRADE) approach was used to assess the quality of evidence. …”
    Get full text
    Article
  2. 282

    Role of Arg1+ ILC2s and ILCregs in gestational diabetes progression by Zhangyun Gong, Haixing Yi, Jie Zhang, Wan Li, Hao Wang, Peipei Guo, Caihua Li, Anan Pan, Yunxia Cao, Zhimin Lu, Huanhuan Jiang

    Published 2025-01-01
    “…The present findings indicate that chronic low-grade inflammation mediated by Arg-1+ILC2s and ILCregs is closely associated with the pathogenesis of GDM.…”
    Get full text
    Article
  3. 283

    The criteria for choice of myocardial revascularization method in patients with stable coronary artery disease in routine clinical practice by O.A. Yepanchintseva, O.J. Zharinov, K.O. Mikhaliev, A.V. Khokhlov, B.M. Todurov

    Published 2018-09-01
    “…CABG group, compared to PCI, was characterized by the higher grade of angina severity, namely the higher frequency of angina III/IV functional classes: 87.9 % vs. 69.1 %, respectively (p < 0.001). …”
    Get full text
    Article
  4. 284

    Automated quantification of anterior chamber cells using swept-source anterior segment optical coherence tomography by Shani Pillar, Shin Kadomoto, Keren Chen, Saitiel Sandoval Gonzalez, Nina Cherian, Joseph K. Privratsky, Nicolette Zargari, Nicholas J. Jackson, Giulia Corradetti, Judy L. Chen, SriniVas R. Sadda, Gary N. Holland, Edmund Tsui

    Published 2025-01-01
    “…ICC comparing automated to manual counts was 0.99 and the Pearson correlation coefficient was 0.98. Eyes at each SUN grade with corresponding median HRF (interquartile range [IQR]) were: Grade 0, 42 eyes, 2 HRF (0,4); 0.5+, 10 eyes, 10 HRF (8,15); 1+, 9 eyes, 22 HRF (15,33); 2+, 3 eyes, 27 HRF; 3+, 2 eyes, 128 HRF; 4+, 1 eye, 474 HRF. …”
    Get full text
    Article
  5. 285
  6. 286
  7. 287

    Statistical Evaluation of the Material-Source Effect on the Ductility and Elastic Recovery (ER) of Plant-Mix Extracted Asphalt-Binders by Lubinda F. Walubita, Gilberto Martinez-Arguelles, Harshavardhan R. Chunduri, Jose G. Gonzalez Hernandez, Luis Fuentes

    Published 2020-01-01
    “…Statistically significant differences were observed among some sources and suppliers that reported the same low-temperature asphalt-binder type/grade (i.e., PG XX-22). Overall, the study contributes to enriching the literature on the material-source effects on asphalt-binders’ ER properties, consistency, variability, and data quality. …”
    Get full text
    Article
  8. 288
  9. 289
  10. 290
  11. 291
  12. 292
  13. 293
  14. 294
  15. 295
  16. 296
  17. 297

    Incidence and risk factors of Vancomycin-induced thrombocytopenia: a six-year real-world study by Yuanchao Zhu, Lishuang Huang, Jingjing Zhang, Liang Liang, Pengfei Jin

    Published 2025-01-01
    “…The severity of thrombocytopenia varied among these patients, with 45.2% (19/42) experiencing Grade 3 to Grade 4 thrombocytopenia. Multivariate analysis indicated that risk factors for VIT were qSOFA score ≥ 2, underlying renal diseases, duration of vancomycin therapy ≥ 8 days, PLT ≤ 150 × 109/L, and BUN ≥ 12 mmol/L. …”
    Get full text
    Article
  18. 298

    Hormonal-Receptors-Positive and HER2-Negative Patients with Metastatic Breast Cancer Treated with First-Line Palbociclib and Hormonal Therapy: Impact of First-Cycle Neutropenia and... by Khaled Abd Elaziz Ahmed Elnaghi, Hosam Ali Alghanmi, Shereef Ahmed Elsamany, Fathia Almarzoki, Mohamed Elsafty, Mohammad Jaffal

    Published 2023-01-01
    “…The median progression-free survival (PFS) of the study group was 22 months. No significant difference was observed in PFS according to the 1st cycle of neutropenia or grade of neutropenia. …”
    Get full text
    Article
  19. 299
  20. 300

    CURRENT APPROACH TO DEVELOPMENT OF BIOSIMILAR PRODUCTS CONTAINING MONOCLONAL ANTIBODIES AS AN ACTIVE SUBSTANCE – NON-CLINICAL AND CLINICAL STUDIES OF THE FIRST RUSSIAN RITUXIMAB BI... by S. M. Alekseev, K. D. Kaplanov, R. A. Ivanov, E. V. Chernyaeva

    Published 2015-04-01
    “…Within the whole study period  the frequency of AEs, including severe AEs (grade 3-4), associated with the use of monotherapy, were equal in both arms without any significant differences. …”
    Get full text
    Article